Evidence map›Paper›PMID 36004556›Full record

ArticleMicrobiologyOpen2022

Discrimination of Escherichia coli, Shigella flexneri, and Shigella sonnei using lipid profiling by MALDI-TOF mass spectrometry paired with machine learning.

Jade Pizzato, Wenhao Tang, Sandrine Bernabeu, Rémy A Bonnin, Emmanuelle Bille, Eric Farfour, Thomas Guillard, Olivier Barraud, Vincent Cattoir, Chloe Plouzeau and 4 more

Abstract read
In one paragraph

Article in MicrobiologyOpen, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Rapid prediction of vancomycin-resistantFrontiers in microbiology · 2026
    Article
  3. A One Health Comparative Study of MDRAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Differentiation ofPathogens (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Differentiation betweenInternational journal of molecular sciences · 2023
    Article
  9. Rapid discrimination ofFrontiers in microbiology · 2023
    Article
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jade PizzatoFaculty of Natural Sciences, Department of Life Sciences, MRC Centre for Molecular Bacteriology & Infection, Imperial College London, England.
Wenhao TangFaculty of Natural Sciences, Department of Mathematics, Imperial College London, England.
Sandrine BernabeuCHU de Bicêtre, Laboratoire de Bactériologie-Hygiène, Assistance Publique des Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
Rémy A BonninINSERM UMR 1184, Team RESIST, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Emmanuelle BilleService de Microbiologie, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, AP-HP Centre-Université de Paris, Paris, France.
Eric FarfourService de Biologie Clinique, Hôpital Foch, Suresnes, France.
Thomas GuillardUniversité de Reims-Champagne-Ardenne, Inserm UMR-S 1250 P3Cell, SFR CAP-Santé, Laboratoire de Bactériologie-Virologie-Hygiène, Hospitalière-Parasitologie-Mycologie, Hôpital Robert Debré, CHU Reims, Reims, France.
Olivier BarraudCHU Limoges, Service de Bactériologie-Virologie-Hygiène, CIC1435, INSERM 1092, Université de Limoges, UMR, Limoges, France.
Vincent CattoirService de Bactériologie-Hygiène, CHU de Rennes, Rennes, France.
Chloe PlouzeauService de Bactériologie et d'Hygiène hospitalière, Unité de microbiologie moléculaire et séquençage, CHU de Poitiers, Poitiers, France.
Stéphane CorvecUniversité de Nantes, CHU Nantes, Service de Bactériologie et des Contrôles Microbiologiques, INSERM, INCIT UMR 1302 F- 44000 Nantes, France.
Vahid ShahrezaeiFaculty of Natural Sciences, Department of Mathematics, Imperial College London, England.
Laurent DortetCHU de Bicêtre, Laboratoire de Bactériologie-Hygiène, Assistance Publique des Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
Gerald Larrouy-MaumusFaculty of Natural Sciences, Department of Life Sciences, MRC Centre for Molecular Bacteriology & Infection, Imperial College London, England.ORCID 0000-0001-6614-8698

Funding

Medical Research Council 105603/Z/14/ZMedical Research Council MC_PC_18050
6 · The paper itself

Abstract

Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) has become a staple in clinical microbiology laboratories. Protein-profiling of bacteria using this technique has accelerated the identification of pathogens in diagnostic workflows. Recently, lipid profiling has emerged as a way to complement bacterial identification where protein-based methods fail to provide accurate results. This study aimed to address the challenge of rapid discrimination between Escherichia coli and Shigella spp. using MALDI-TOF MS in the negative ion mode for lipid profiling coupled with machine learning. Both E. coli and Shigella species are closely related; they share high sequence homology, reported for 16S rRNA gene sequence similarities between E. coli and Shigella spp. exceeding 99%, and a similar protein expression pattern but are epidemiologically distinct. A bacterial collection of 45 E. coli, 48 Shigella flexneri, and 62 Shigella sonnei clinical isolates were submitted to lipid profiling in negative ion mode using the MALDI Biotyper Sirius® system after treatment with mild-acid hydrolysis (acetic acid 1% v/v for 15 min at 98°C). Spectra were then analyzed using our in-house machine learning algorithm and top-ranked features used for the discrimination of the bacterial species. Here, as a proof-of-concept, we showed that lipid profiling might have the potential to differentiate E. coli from Shigella species using the analysis of the top five ranked features obtained by MALDI-TOF MS in the negative ion mode of the MALDI Biotyper Sirius® system. Based on this new approach, MALDI-TOF MS analysis of lipids might help pave the way toward these goals.

Indexed as

Escherichia coli InfectionsShigellaBacteriaEscherichia coliHumansLipidsMachine LearningRNA, Ribosomal, 16SShigella flexneriShigella sonneiSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationLipidsRNA, Ribosomal, 16SidentificationlipidsMALDIShigella

Identifiers

PMID36004556
PMCPMC9405496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.